Cargando…
When do we need clinical endpoint adjudication in clinical trials?
Clinical endpoint adjudication (CEA) is a standardized process for assessment of safety and efficacy of pharmacologic or device therapies in clinical trials. CEA plays a key role in many large clinical trials with the aim of achieving consistency and accuracy of the study results, by applying indepe...
Autor principal: | Held, Claes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454409/ https://www.ncbi.nlm.nih.gov/pubmed/30427257 http://dx.doi.org/10.1080/03009734.2018.1516706 |
Ejemplares similares
-
Clinical Trials: Minimising source data queries to streamline endpoint adjudication in a large multi-national trial
por: Tolmie, Elizabeth P, et al.
Publicado: (2011) -
Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial
por: Hata, Jun, et al.
Publicado: (2013) -
Is more involvement needed in the clinical trial design & endpoints?
por: Vroom, Elizabeth
Publicado: (2012) -
When do we need to do meta-analysis!!!
por: Soni, Kapil D.
Publicado: (2023) -
Importance of swift event adjudication of endpoints for adequate reporting to data and safety monitoring boards in clinical trials—lessons from CULPRIT-SHOCK
por: Clemmensen, Peter, et al.
Publicado: (2021)